Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : IPHA    crawled time : 14:02    save search
 Innate Pharma to present additional efficacy data for monalizumab in combination with cetuximab in head and neck cancer at the ESMO immuno-oncology virtual congress
Published: 2020-12-03 (Crawled : 14:02) - globenewswire.com
IPHA | $2.48 5.53% 5.24% 9.4K twitter stocktwits trandingview |
Health Technology
 | | O: 7.17% H: 1.27% C: -3.8%
cancer
Gainers vs Losers
67% 33%

Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.